W.R. Berkley Corp’s Zura Bio ZURA Stock Holding History

W.R. Berkley Corp’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-339,678	Closed	-$3.47M	–	250
2022 Q4	$3.47M	Buy	339,678 +99,500	+41%	+$1.01M	0.19%	89
2022 Q3	$2.41M	Buy	240,178 +119,162	+98%	+$1.19M	0.12%	181
2022 Q2	$1.2M	Hold	121,016	–	–	0.06%	313
2022 Q1	$1.2M	Hold	121,016	–	–	0.06%	319
2021 Q4	$1.19M	Hold	121,016	–	–	0.07%	318
2021 Q3	$1.18M	Buy	+121,016	New	+$1.19M	0.08%	223

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

W.R. Berkley Corp's ZURA Position: Q1 2023 in Review

W.R. Berkley Corp sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 339,678 shares — an estimated $3.47M sold.

W.R. Berkley Corp first reported a position in ZURA in Q3 2021 and held it in 6 quarters. The position peaked at $3.47M in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

W.R. Berkley Corp reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
W.R. Berkley Corp sold 339,678 Zura Bio shares in Q1 2023, an estimated $3.47M.
W.R. Berkley Corp first reported a position in Zura Bio in Q3 2021 and held it in 6 quarters.
W.R. Berkley Corp's Zura Bio position peaked at $3.47M in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on W.R. Berkley Corp's 13F filing for Q1 2023, filed 15 May 2023.